Enovis PE Ratio 2010-2025 | ENOV

Current and historical p/e ratio for Enovis (ENOV) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Enovis PE ratio as of July 15, 2025 is 10.18.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Enovis PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-15 30.90 0.00
2025-03-31 38.21 $-13.95 0.00
2024-12-31 43.88 $-14.29 0.00
2024-09-30 43.05 $-2.19 0.00
2024-06-30 45.20 $-1.66 0.00
2024-03-31 62.45 $-1.50 0.00
2023-12-31 56.02 $-0.61 0.00
2023-09-30 52.73 $-1.37 0.00
2023-06-30 64.12 $-2.55 0.00
2023-03-31 53.49 $-0.96 0.00
2022-12-31 53.52 $-0.20 0.00
2022-09-30 46.07 $0.48 95.98
2022-06-30 55.00 $2.19 25.11
2022-03-31 68.44 $1.32 51.84
2021-12-31 79.06 $1.38 57.28
2021-09-30 78.94 $2.13 37.06
2021-06-30 78.79 $1.95 40.40
2021-03-31 75.35 $1.23 61.25
2020-12-31 65.77 $0.93 70.71
2020-09-30 53.94 $-0.15 0.00
2020-06-30 47.99 $-0.21 0.00
2020-03-31 34.05 $-10.38 0.00
2019-12-31 62.57 $-11.64 0.00
2019-09-30 49.98 $-10.11 0.00
2019-06-30 48.21 $-9.57 0.00
2019-03-31 51.05 $1.71 29.85
2018-12-31 35.95 $3.48 10.33
2018-09-30 62.02 $2.61 23.76
2018-06-30 52.72 $2.94 17.93
2018-03-31 54.87 $3.30 16.62
2017-12-31 68.14 $3.63 18.77
2017-09-30 71.62 $4.26 16.81
2017-06-30 67.71 $3.84 17.63
2017-03-31 67.52 $3.51 19.24
2016-12-31 61.80 $3.12 19.80
2016-09-30 54.06 $3.27 16.53
2016-06-30 45.51 $3.03 15.02
2016-03-31 49.17 $3.33 14.76
2015-12-31 40.16 $4.05 9.92
2015-09-30 51.44 $4.89 10.52
2015-06-30 79.37 $6.21 12.78
2015-03-31 82.09 $9.54 8.60
2014-12-31 88.70 $8.94 9.92
2014-09-30 97.98 $7.95 12.32
2014-06-30 128.20 $7.62 16.82
2014-03-31 122.68 $4.59 26.73
2013-12-31 109.54 $4.56 24.02
2013-09-30 97.16 $4.02 24.17
2013-06-30 89.62 $2.70 33.19
2013-03-31 80.04 $1.35 59.29
2012-12-31 69.40 $-3.27 0.00
2012-09-30 63.07 $-4.77 0.00
2012-06-30 47.42 $-4.65 0.00
2012-03-31 60.61 $-4.17 0.00
2011-12-31 48.98 $0.27 181.35
2011-09-30 34.85 $1.98 17.60
2011-06-30 42.65 $2.13 20.02
2011-03-31 39.47 $1.59 24.82
2010-12-31 31.66 $1.08 29.32
2010-09-30 25.58 $0.84 30.45
2010-06-30 17.90 $0.57 31.41
2010-03-31 20.24 $0.72 28.12
2009-12-31 20.71 $1.26 16.43
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.826B $2.108B
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.128B 58.69
Hims & Hers Health (HIMS) United States $11.646B 121.00
Doximity (DOCS) United States $11.561B 53.52
Tempus AI (TEM) United States $10.010B 0.00
IRhythm Technologies (IRTC) United States $4.435B 0.00
Inspire Medical Systems (INSP) United States $3.842B 60.03
Hinge Health (HNGE) United States $3.739B 0.00
Privia Health (PRVA) United States $2.547B 174.08
Phreesia (PHR) United States $1.642B 0.00
Schrodinger (SDGR) United States $1.551B 0.00
10x Genomics (TXG) United States $1.535B 0.00
Clover Health Investments (CLOV) United States $1.527B 0.00
Azenta (AZTA) United States $1.475B 68.57
Evolent Health (EVH) United States $1.334B 113.60
Omnicell (OMCL) United States $1.291B 22.78
Claritev (CTEV) United States $0.763B 0.00
Fulgent Genetics (FLGT) United States $0.582B 0.00
Veradigm (MDRX) United States $0.547B 0.00
Standard BioTools (LAB) United States $0.475B 0.00
Butterfly Network (BFLY) United States $0.450B 0.00
Talkspace (TALK) United States $0.430B 128.50
Outset Medical (OM) United States $0.333B 0.00
TruBridge (TBRG) United States $0.329B 731.00
Health Catalyst (HCAT) United States $0.269B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.231B 0.00
CapsoVision (CV) United States $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.149B 0.00
Zepp Health (ZEPP) Netherlands $0.139B 0.00
American Well (AMWL) United States $0.126B 0.00
EUDA Health Holdings (EUDA) Singapore $0.122B 0.00
Pulmonx (LUNG) United States $0.108B 0.00
MDxHealth SA (MDXH) Belgium $0.104B 0.00
CareCloud (CCLD) United States $0.098B 3.73
ImmunoPrecise Antibodies (IPA) Canada $0.091B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.081B 0.00
111 (YI) China $0.064B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.042B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00